title: Developmental effects of SSRIs: lessons learned from animal studies.
abstract: Selective serotonin reuptake inhibitors (SSRIs) are utilized in the treatment of depression in pregnant and lactating women. SSRIs may be passed to the fetus through the placenta and the neonate through breastfeeding, potentially exposing them to SSRIs during peri- and postnatal development. However, the long-term effects of this SSRI exposure are still largely unknown. The simplicity and genetic amenability of model organisms provides a critical experimental advantage compared to studies with humans. This review will assess the current research done in animals that sheds light on the role of serotonin during development and the possible effects of SSRIs. Experimental studies in rodents show that administration of SSRIs during a key developmental window creates changes in brain circuitry and maladaptive behaviors that persist into adulthood. Similar changes result from the inhibition of the serotonin transporter or monoamine oxidase, implicating these two regulators of serotonin signaling in developmental changes. Understanding the role of serotonin in brain development is critical to identifying the possible effects of SSRI exposure.
authors: University of Virginia Medical Scientist Training Program and University of Virginia Neuroscience Graduate Program, Charlottesville, VA 22904, USA.
authors: Xenia
authors: X
authors: Borue
authors: John
authors: J
authors: Chen
authors: Barry G
authors: BG
authors: Condron
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000196:embryology* / Q000503:physiopathology; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008995:Monoamine Oxidase / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D012701:Serotonin / Q000378:metabolism / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000187:drug effects / Q000378:metabolism; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology
chemical_list: D008995:Monoamine Oxidase; D012701:Serotonin; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors
references: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12730-5
references: 11675504
references: J Neurosci. 2001 Sep 1;21(17):6862-73
references: 11517274
references: Physiol Behav. 2002 Mar;75(3):403-10
references: 11897268
references: Pharmacogenomics J. 2002;2(4):217-35
references: 12196911
references: J Neurosci. 2002 Oct 1;22(19):8541-52
references: 12351728
references: Endocrinology. 2002 Dec;143(12):4520-6
references: 12446578
references: Neuron. 2003 Jan 23;37(2):233-47
references: 12546819
references: Am J Psychiatry. 2003 May;160(5):993-6
references: 12727706
references: Brain Res Bull. 2003 May 30;60(4):345-53
references: 12781323
references: J Neurochem. 2003 Jul;86(1):210-9
references: 12807440
references: Science. 2003 Jul 18;301(5631):386-9
references: 12869766
references: Dev Neurosci. 2003 Mar-Aug;25(2-4):245-56
references: 12966221
references: Behav Pharmacol. 2003 Sep;14(5-6):369-83
references: 14501251
references: Nat Rev Neurosci. 2003 Dec;4(12):1002-12
references: 14618156
references: Biol Psychiatry. 2003 Nov 15;54(10):953-9
references: 14625137
references: Biol Psychiatry. 2003 Nov 15;54(10):960-71
references: 14625138
references: Neuropsychopharmacology. 2003 Dec;28(12):2077-88
references: 12968128
references: Genes Brain Behav. 2003 Dec;2(6):365-80
references: 14653308
references: Development. 2004 Mar;131(5):997-1006
references: 14973268
references: J Neurosci. 2004 Feb 18;24(7):1652-9
references: 14973240
references: Mol Interv. 2004 Apr;4(2):109-23
references: 15087484
references: Brain Res Dev Brain Res. 2004 Jun 21;150(2):151-61
references: 15158078
references: Am J Psychiatry. 2004 Jun;161(6):1066-78
references: 15169695
references: Neuroreport. 2004 Sep 15;15(13):2097-101
references: 15486489
references: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15506-11
references: 15483108
references: Science. 2004 Oct 29;306(5697):879-81
references: 15514160
references: Brain Res. 1981 Jan 5;204(1):129-46
references: 7195762
references: Proc Natl Acad Sci U S A. 1987 Jun;84(12):4322-6
references: 3473503
references: EXS. 1993;63:266-78
references: 8422538
references: J Neurobiol. 1994 Jun;25(6):666-93
references: 8071666
references: J Comp Neurol. 1994 Oct 8;348(2):277-90
references: 7814692
references: Neuron. 1995 May;14(5):899-912
references: 7748558
references: Neuron. 1996 Nov;17(5):823-35
references: 8938116
references: Curr Biol. 1997 Oct 1;7(10):813-6
references: 9368767
references: J Pharmacol Exp Ther. 1997 Dec;283(3):1333-41
references: 9400008
references: Neuron. 1997 Dec;19(6):1285-96
references: 9427251
references: Mol Pharmacol. 1998 Apr;53(4):649-55
references: 9547354
references: Eur J Pharmacol. 1998 Jul 10;352(2-3):307-15
references: 9716368
references: J Neural Transm (Vienna). 1998;105(10-12):1335-9
references: 9928901
references: J Neurosci. 1999 Aug 15;19(16):7007-24
references: 10436056
references: Neuropharmacology. 1999 Aug;38(8):1083-152
references: 10462127
references: Chin J Physiol. 1999 Jun 30;42(2):53-9
references: 10513599
references: J Neurosci Methods. 2004 Dec 30;140(1-2):169-81
references: 15589347
references: Am J Med Genet B Neuropsychiatr Genet. 2005 Feb 5;133B(1):110-5
references: 15578606
references: Int J Dev Neurosci. 2005 Feb;23(1):75-83
references: 15730889
references: Neuron. 2005 Apr 7;46(1):65-74
references: 15820694
references: Mol Psychiatry. 2005 Aug;10(8):782-9, 714
references: 15940298
references: Neuropharmacology. 2005 Nov;49(6):798-810
references: 16183083
references: Neuropsychopharmacology. 2006 Jan;31(1):47-57
references: 16012532
references: Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6269-74
references: 16569698
references: J Neurosci. 2006 May 17;26(20):5554-64
references: 16707806
references: Mol Neurobiol. 2006 Aug;34(1):51-66
references: 17003521
references: Behav Brain Res. 2007 Jan 10;176(1):94-108
references: 17034875
references: Cereb Cortex. 2000 Feb;10(2):181-91
references: 10667986
references: Pediatrics. 2000 Apr;105(4 Pt 1):880-7
references: 10742343
references: J Neurosci. 2001 Feb 1;21(3):884-96
references: 11157075
references: Psychopharmacology (Berl). 2001 May;155(3):315-22
references: 11432695
references: Brain Res Bull. 2001 Nov 15;56(5):487-94
references: 11750794